statistiche ricercatore

Continente	#
NA - Nord America	997
EU - Europa	491
AS - Asia	392
SA - Sud America	55
AF - Africa	15
OC - Oceania	2
Continente sconosciuto - Info sul continente non disponibili	1
Totale	1.953

Nazione	#
US - Stati Uniti d'America	983
IT - Italia	179
SG - Singapore	140
CN - Cina	101
HK - Hong Kong	65
DE - Germania	61
SE - Svezia	60
GB - Regno Unito	49
RU - Federazione Russa	37
BR - Brasile	31
FI - Finlandia	27
VN - Vietnam	24
FR - Francia	22
ID - Indonesia	16
AR - Argentina	15
IN - India	9
BG - Bulgaria	8
CA - Canada	8
KR - Corea	8
NL - Olanda	8
PL - Polonia	8
TR - Turchia	8
LT - Lituania	6
SI - Slovenia	6
ZA - Sudafrica	6
JP - Giappone	5
CZ - Repubblica Ceca	4
MA - Marocco	4
RO - Romania	4
AT - Austria	3
EC - Ecuador	3
ES - Italia	3
IR - Iran	3
MY - Malesia	3
AU - Australia	2
BE - Belgio	2
CL - Cile	2
EG - Egitto	2
IQ - Iraq	2
MX - Messico	2
PE - Perù	2
SN - Senegal	2
UZ - Uzbekistan	2
A2 - ???statistics.table.value.countryCode.A2???	1
CO - Colombia	1
DO - Repubblica Dominicana	1
EE - Estonia	1
GE - Georgia	1
GH - Ghana	1
HT - Haiti	1
IE - Irlanda	1
LA - Repubblica Popolare Democratica del Laos	1
LV - Lettonia	1
PA - Panama	1
PH - Filippine	1
PK - Pakistan	1
PS - Palestinian Territory	1
TM - Turkmenistan	1
TT - Trinidad e Tobago	1
UA - Ucraina	1
VE - Venezuela	1
Totale	1.953

Nome	#
Machine learning in predicting respiratory failure in patients with COVID-19 pneumonia - challenges, strengths, and opportunities in a global health emergency.	311
Better prognosis in females with severe COVID-19 pneumonia: possible role of inflammation as potential mediator.	277
Hypokalemia in Patients with COVID-19	268
Peritoneal dialysis in the time of coronavirus disease 2019	248
Darunavir/Cobicistat Is Associated with Negative Outcomes in HIV-Negative Patients with Severe COVID-19 Pneumonia	228
The impact of tocilizumab on respiratory support states transition and clinical outcomes in COVID-19 patients. A Markov model multi-state study	213
Epidemiology and Risk Factors Associated with Mortality in Consecutive Patients with Bacterial Bloodstream Infection: Impact of MDR and XDR Bacteria	196
Prospective Study on Incidence, Risk Factors and Outcome of Recurrent Clostridioides difficile Infections	132
Efficacy of bezlotoxumab in preventing recurrence of Clostridioides difficile infection: an Italian multicenter cohort study	109
Totale	1.982

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	253	0	0	0	0	0	15	85	26	20	27	41	39
2021/2022	306	23	25	23	10	13	14	41	16	34	21	48	38
2022/2023	251	34	30	30	20	29	25	8	20	24	4	11	16
2023/2024	185	1	9	17	19	22	27	12	32	9	3	14	20
2024/2025	505	21	11	7	31	88	81	40	33	51	27	49	66
2025/2026	453	66	50	76	95	123	43	0	0	0	0	0	0
Totale													1.982